Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II

Published:2010-01 Issue:1 Volume:13 Page:8-13
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Garrison Louis P.,Mansley Edward C.,Abbott Thomas A.,Bresnahan Brian W.,Hay Joel W.,Smeeding James

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference18 articles.

1. Cost-effectiveness in Health and Medicine,1996

2. Inconsistencies in the “societal perspective” on costs of the Panel on Cost-Effectiveness in Health and Medicine;Meltzer;Med Decis Making,1999

3. Health Care Cost, Quality, and Outcomes: ISPOR Book of Terms,2003

4. Methods for the Economic Evaluation of Health Care Programmes;Drummond,2005

5. Estimating costs in cost-effectiveness analysis;Luce,1996

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality-of-life survey of pancreatic cancer patients: a comparison between general public and physicians;Frontiers in Health Services;2024-07-12

2. Methods for Measuring and Valuing Informal Care: A Systematic Review and Meta-Analysis in Stroke;Value in Health;2024-07

3. TREAT-B or Treat All: time for a broader vision on hepatitis B elimination – Author's reply;The Lancet Global Health;2024-06

4. An overview of the perspectives used in health economic evaluations;Cost Effectiveness and Resource Allocation;2024-05-14

5. Developing a Program Costs Checklist of Digital Health Interventions: A Scoping Review and Empirical Case Study;PharmacoEconomics;2024-03-26